BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 15,000 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of C$3.82, for a total transaction of C$57,300.00. Following the sale, the director directly owned 397,370 shares of the company’s stock, valued at C$1,517,953.40. The trade was a 3.64% decrease in their position.
BioRem Trading Up 4.7%
Shares of BRM stock traded up C$0.17 during mid-day trading on Monday, reaching C$3.80. The stock had a trading volume of 45,331 shares, compared to its average volume of 26,106. The stock’s 50-day moving average price is C$3.30 and its two-hundred day moving average price is C$2.99. BioRem Inc. has a 52-week low of C$1.87 and a 52-week high of C$3.95. The firm has a market capitalization of C$61.69 million, a PE ratio of 11.31 and a beta of 0.81. The company has a current ratio of 2.04, a quick ratio of 1.08 and a debt-to-equity ratio of 14.17.
About BioRem
Featured Stories
- Five stocks we like better than BioRem
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
